Uraemic Toxins and Cardiovascular Disease: Research Versus Clinical Outcome Studies

Overview

Journal NDT Plus

Publisher Oxford University Press

Specialty Nephrology

Date 2019 Feb 23

PMID 30792775

Citations 5

Authors

Raymond Vanholder

Steven van Laecke

Francis Verbeke

Griet Glorieux

Wim Van Biesen

Affiliations

Soon will be listed here.

Citing Articles

In Vitro Induction of Eryptosis by Uremic Toxins and Inflammation Mediators in Healthy Red Blood Cells.

Virzi G, Mattiotti M, Clementi A, Milan Manani S, Battaglia G, Ronco C J Clin Med. 2022; 11(18).

PMID: 36142976 PMC: 9501441. DOI: 10.3390/jcm11185329.

High cut-off dialysis mitigates pro-calcific effects of plasma on vascular progenitor cells.

Schaub T, Janke D, Zickler D, Lange C, Girndt M, Schindler R Sci Rep. 2021; 11(1):1144.

PMID: 33441772 PMC: 7807056. DOI: 10.1038/s41598-020-80016-7.

Removal of large middle molecules via haemodialysis with medium cut-off membranes at lower blood flow rates: an observational prospective study.

Kim T, Kim S, Kim T, Park H, Jung K, Lee M BMC Nephrol. 2020; 21(1):2.

PMID: 31892319 PMC: 6937993. DOI: 10.1186/s12882-019-1669-3.

The Relationship of Residual Renal Function with Cardiovascular Morbidity in Hemodialysis Patients and the Potential Role of Monocyte Chemoattractant Protein-1.

Raikou V, Kardalinos V, Kyriaki D Kidney Dis (Basel). 2018; 4(1):20-28.

PMID: 29594139 PMC: 5848486. DOI: 10.1159/000484603.

The relationship between glycemic control, beta2-microglobulin and inflammation in patients on maintenance dialysis treatment.

Raikou V, Kyriaki D J Diabetes Metab Disord. 2015; 14:34.

PMID: 25922828 PMC: 4412206. DOI: 10.1186/s40200-015-0162-1.

References

Stenvinkel P, Heimburger O, Paultre F, Diczfalusy U, Wang T, Berglund L . Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney Int. 1999; 55(5):1899-911. DOI: 10.1046/j.1523-1755.1999.00422.x. View

Locatelli F, Hannedouche T, Jacobson S, La Greca G, Loureiro A, Martin-Malo A . The effect of membrane permeability on ESRD: design of a prospective randomised multicentre trial. J Nephrol. 1999; 12(2):85-8. View

Touam M, Zingraff J, Jungers P, Chadefaux-Vekemans B, Drueke T, Massy Z . Effective correction of hyperhomocysteinemia in hemodialysis patients by intravenous folinic acid and pyridoxine therapy. Kidney Int. 1999; 56(6):2292-6. DOI: 10.1046/j.1523-1755.1999.00792.x. View

van Guldener C, Lambert J, Ter Wee P, Donker A, Stehouwer C . Carotid artery stiffness in patients with end-stage renal disease: no effect of long-term homocysteine-lowering therapy. Clin Nephrol. 2000; 53(1):33-41. View

Woods H, Nandakumar M . Improved outcome for haemodialysis patients treated with high-flux membranes. Nephrol Dial Transplant. 2000; 15 Suppl 1:36-42. DOI: 10.1093/oxfordjournals.ndt.a027962. View

Cheung A, Sarnak M, Yan G, Dwyer J, Heyka R, Rocco M . Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients. Kidney Int. 2000; 58(1):353-62. DOI: 10.1046/j.1523-1755.2000.00173.x. View

Jono S, McKee M, Murry C, Shioi A, Nishizawa Y, Mori K . Phosphate regulation of vascular smooth muscle cell calcification. Circ Res. 2000; 87(7):E10-7. DOI: 10.1161/01.res.87.7.e10. View

Massy Z, Ceballos I, Nguyen-Khoa T, Descamps-Latscha B, Drueke T, Jungers P . Homocyst(e)ine, oxidative stress, and endothelium function in uremic patients. Kidney Int Suppl. 2001; 78:S243-5. DOI: 10.1046/j.1523-1755.2001.59780243.x. View

Steppan C, Bailey S, Bhat S, Brown E, Banerjee R, Wright C . The hormone resistin links obesity to diabetes. Nature. 2001; 409(6818):307-12. DOI: 10.1038/35053000. View

10.

Jankowski J, Hagemann J, Yoon M, van der Giet M, Stephan N, Zidek W . Increased vascular growth in hemodialysis patients induced by platelet-derived diadenosine polyphosphates. Kidney Int. 2001; 59(3):1134-41. DOI: 10.1046/j.1523-1755.2001.0590031134.x. View

11.

Foley R, Parfrey P, Sarnak M . Epidemiology of cardiovascular disease in chronic renal disease. J Am Soc Nephrol. 2001; 9(12 Suppl):S16-23. View

12.

Zoccali C, Mallamaci F, Benedetto F, Tripepi G, Malatino L, Cataliotti A . Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study. Lancet. 2002; 358(9299):2113-7. DOI: 10.1016/s0140-6736(01)07217-8. View

13.

Vanholder R, Argiles A, Baurmeister U, Brunet P, Clark W, Cohen G . Uremic toxicity: present state of the art. Int J Artif Organs. 2002; 24(10):695-725. View

14.

Eknoyan G, Beck G, Cheung A, Daugirdas J, Greene T, Kusek J . Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med. 2002; 347(25):2010-9. DOI: 10.1056/NEJMoa021583. View

15.

De Smet R, Van Kaer J, Van Vlem B, De Cubber A, Brunet P, Lameire N . Toxicity of free p-cresol: a prospective and cross-sectional analysis. Clin Chem. 2003; 49(3):470-8. DOI: 10.1373/49.3.470. View

16.

Jankowski J, Jankowski V, Laufer U, van der Giet M, Henning L, Tepel M . Identification and quantification of diadenosine polyphosphate concentrations in human plasma. Arterioscler Thromb Vasc Biol. 2003; 23(7):1231-8. DOI: 10.1161/01.ATV.0000075913.00428.FD. View

17.

Kielstein J, Becker B, Graf S, Brabant G, Haller H, Fliser D . Increased resistin blood levels are not associated with insulin resistance in patients with renal disease. Am J Kidney Dis. 2003; 42(1):62-6. DOI: 10.1016/s0272-6386(03)00409-8. View

18.

Jankowski J, van der Giet M, Jankowski V, Schmidt S, Hemeier M, Mahn B . Increased plasma phenylacetic acid in patients with end-stage renal failure inhibits iNOS expression. J Clin Invest. 2003; 112(2):256-64. PMC: 164281. DOI: 10.1172/JCI15524. View

19.

Bolasco P, Altieri P, Andrulli S, Basile C, di Filippo S, Feriani M . Convection versus diffusion in dialysis: an Italian prospective multicentre study. Nephrol Dial Transplant. 2003; 18 Suppl 7:vii50-4; discussion vii59-62. DOI: 10.1093/ndt/gfg1080. View

20.

Bammens B, Evenepoel P, Verbeke K, Vanrenterghem Y . Removal of middle molecules and protein-bound solutes by peritoneal dialysis and relation with uremic symptoms. Kidney Int. 2003; 64(6):2238-43. DOI: 10.1046/j.1523-1755.2003.00310.x. View